Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 6 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 11898207

    Methods of isolating neoantigen-specific T cell receptor sequences

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 13, 2024 · Expires Feb 8, 2044

    granted
  2. US 11890339

    Nipah virus immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 6, 2024 · Expires Feb 1, 2044

    granted
  3. US 11883431

    T-cells modified to overexpress PHF19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 30, 2024 · Expires Jan 25, 2044

    granted
  4. US 11879017

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  5. US 11878998

    Prefusion RSV F proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  6. US 11878064

    Nanoparticle/peptide method of blocking potassium channels

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted Jan 23, 2024 · Expires Jan 18, 2044

    granted
  7. US 11872261

    Lipoprotein targeting protease inhibitors and uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 16, 2024 · Expires Jan 11, 2044

    granted
  8. US 11865168

    Compositions and methods for treating bacterial infections

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  9. US 11850236

    Method for inhibiting Zika virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  10. US 11851498

    Anti-CD276 antibodies (B7H3)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 26, 2023 · Expires Dec 21, 2043

    granted
  11. US 11845778

    Prefusion PIV F immunogens and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  12. US 11844769

    Use of cysteamine and derivatives thereof to suppress tumor metastases

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2023 · Expires Dec 14, 2043

    granted
  13. US 11840561

    Anti-KRAS-G12D T cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 12, 2023 · Expires Dec 7, 2043

    granted
  14. US 11833199

    Peptide fragments from filoviruses and their uses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  15. US 11834509

    Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  16. US 11813319

    Development of a novel live attenuated African Swine Fever vaccine based in the deletion of gene I177L

    The United States of America, as represented by the Secretary of Agriculture · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  17. US 11814440

    Glypican 2 as a cancer marker and therapeutic target

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  18. US 11813316

    Lentiviral vector for treating hemoglobin disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  19. US 11807682

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Heath and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  20. US 11806369

    Exosomes and miRNA to treat glaucoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  21. US 11806406

    Virus-like particle conjugates for diagnosis and treatment of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 7, 2023 · Expires Nov 2, 2043

    granted
  22. US 11801296

    Development of a novel live attenuated African swine fever vaccine based in the deletion of gene A137R

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 31, 2023 · Expires Oct 26, 2043

    granted
  23. US 11793870

    Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted
  24. US 11795235

    Immunotoxins with albumin binding domain

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 24, 2023 · Expires Oct 19, 2043

    granted